The funding round includes investment from the South West Investment Fund, managed by The FSE Group.
"Circular 11 is addressing a clear challenge in the construction and materials market. The team has developed a compelling approach to turning difficult-to-recycle plastic into useful, long-life products, and this investment will help the business scale its operations and build on early commercial traction."
The biotechnology firm secured backing from the South West Investment Fund to expand manufacturing capabilities.
"We’re delighted to provide this investment from the South West Investment Fund to support genuinely breakthrough materials science in the delivery of meaningful carbon reductions. With strong commercial interest already in place and a clear plan to scale production, Mykor is well-positioned to play a significant role in decarbonising the built environment while building a high-growth, internationally relevant business."
The investment was backed by the South West Investment Fund via The FSE Group.
"Difficulty taking tablets is a common problem in paediatrics but extends to adults experiencing swallow impairment, including those suffering from serious conditions such as stroke, dementia and some forms of cancer. Our liquid products are effective and stable at room temperature with a long shelf life, improving medication adherence, dosage accuracy and convenience for the NHS, patients, and caregivers. We are thrilled to receive this investment, which will help us make a significant impact on the global pharmaceutical landscape."